Making a difference to many

Making a difference to many

15 March 2019

I was one of six children to adventurous and curious parents. We lived in various countries around the globe, including Italy and the US, and our way of doing things was always a little unconventional. When we went on holidays, we went camping in famous European cities and slept in ‘sleeping sheets’ that my mother had sewn from scraps of material with kid-friendly prints. From my father, I learned to ‘work hard and play hard.’ A family joke was that a 30-minute bushwalk with my parents could take upwards of 2 hours, given that we had to examine every native plant along the track. My father, who was an anesthesiologist, and my mother, who taught and researched public health, never pressured us to follow them in their medical careers. But my mother would often talk about the joys of impacting people’s lives with epidemiological research and public health policies. Her mantra of ‘making a difference to many’ really struck a chord with me.

I grew up reading the medical books my parents owned. This might be why after completing a PhD in chemistry (supervised by a powerhouse of a mentor, Margaret Harding) and a Fulbright postdoctoral fellowship with Reza Ghadiri at The Scripps Research Institute in California, I felt that my chemistry PhD could be supplemented with in-depth medical knowledge. So I went to medical school, which I completed in 2000.

A sliding doors moment came a few years later when I had a chance meeting with the Australian pathologist Richard Scolyer. I had just had my third baby and completed my oncology training, and I was considering which area of cancer to specialize in. Richard cycled past my backyard in Sydney and stopped to chat. “You’re crazy if you don’t get into melanoma,” he said. He explained that we Australians have one of the highest incidences of the disease in the world, with no effective drug therapies. Becoming a melanoma specialist would therefore be a huge opportunity to effect change.

Melanoma and its risks were not new to me. My father would warn us of the risk of damage from ultraviolet rays and would wear long-sleeved shirts and wide-brimmed hats outdoors at a time when sunburns weren’t thought of as seriously as they are today. Later, in medical school, I had researched melanoma of the head and neck. So when Richard suggested melanoma as a specialization, I think a part of me was already ready for it.

I loved studying cancer. There were many opportunities to perform research and to make a difference in melanoma. My first four years as a medical oncologist and translational researcher were self-funded by grants I wrote. At the time, despite having three children, the oldest of whom was 4, I was not allowed to take the grant part-time. This was challenging, as I had to juggle schedules at home, the clinic and the research lab.

Fast-forward more than a decade, and Scolyer are I are now co-medical directors of Melanoma Institute Australia. We are working towards what was once unthinkable—zero deaths from melanoma. My work now focuses on targeted and immune therapies in melanoma, which have significantly improved the survival of patients with advanced melanoma and have even cured some. When I entered the melanoma field, more than 90% of patients with advanced melanoma did not live longer than three years after diagnosis. Now, more than 50% of patients make it past three years.

However, many challenges remain. Determining specific mechanisms of resistance, which is a growing problem, is a current research focus in our laboratory. We’re also testing different ways to administer drugs. Trials in patients with stage III cancers suggest immunotherapy works better before surgery than after, and we think that this is because the presence of the tumor helps elicit a stronger antitumor response from the immune system.

Reflecting on my career path brings to mind so many influences, both people and experiences, that were critical to my career. I am a proud mum to three teenage daughters and have achieved all these things with the support of my free-thinking and visionary husband Greg, who predicted that there’d be a huge wave in melanoma research and that I had to catch it. With the continued support of my family and colleagues, I look forward to achieving zero deaths from melanoma in my lifetime and to making a difference to many.


This was originally published in Nature Medicine | Turning points | FOCUS | VOL 25 | MARCH 2019 | 356–357 | www.nature.com/naturemedicine |

Published online: 6 March 2019 https://doi.org/10.1038/s41591-019-0390-x

 

 

International Clinical Trials Day 2019
20 May 2019

International Clinical Trials Day 2019

Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.

Emma Betts' legacy will live on
17 May 2019

Emma Betts' legacy will live on

“I’m the age Emma was when she passed away. It almost feels unfair, that she has to not be here for me to be able to do this. But I will use this opportunity to push as hard as I can to reach our collective goal of zero deaths from melanoma.”

Support PBS listing for adjuvant treatments of resected Stage III melanoma
13 May 2019

Support PBS listing for adjuvant treatments of resected Stage III melanoma

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

Support PBS listing for pembrolizumab
06 May 2019

Support PBS listing for pembrolizumab

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

How are the Premier's Awards helping cancer researchers?
02 May 2019

How are the Premier's Awards helping cancer researchers?

MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
19 Mar 2019

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects

Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.

Making a difference to many
15 Mar 2019

Making a difference to many

Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March
26 Feb 2019

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March

Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

Melanoma breakthrough paves way for personalised treatment for all cancer patients
14 Feb 2019

Melanoma breakthrough paves way for personalised treatment for all cancer patients

Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.

Melanoma March announces 2019 Principal Partner
07 Feb 2019

Melanoma March announces 2019 Principal Partner

Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma
05 Feb 2019

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma

World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

MIA experts collaborate on groundbreaking research
16 Jan 2019

MIA experts collaborate on groundbreaking research

MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA
20 Dec 2018

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA

MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.

Possible PBS listing for dabrafenib and trametinib
18 Dec 2018

Possible PBS listing for dabrafenib and trametinib

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.

Arden Anglican School wins SunSafe Ambassador competition
13 Dec 2018

Arden Anglican School wins SunSafe Ambassador competition

Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award.

DON'T CLOUD THE SUN-SAFE MESSAGE
08 Dec 2018

DON'T CLOUD THE SUN-SAFE MESSAGE

Mark Whittaker’s ‘Here comes the sun; Defending our summer rays’ (GW 24 Nov) clouds the sun-safe message – which could have disastrous consequences.

Professor Georgina Long named as one of world's most highly cited researchers
04 Dec 2018

Professor Georgina Long named as one of world's most highly cited researchers

Professor Georgina Long is among only 12 researchers from the University of Sydney to be named in the 2018 Highly Cited Researchers List.

Aussies need to protect themselves from 'everyday' sun damage
01 Dec 2018

Aussies need to protect themselves from 'everyday' sun damage

‘Wearing sunscreen should be as automatic as wearing a seatbelt. Both are potential life savers.

The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma
29 Nov 2018

The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma

A prestigious $10 million Australian Cancer Research Foundation grant has been awarded to ACEMID, an initiative that aims to use 3D total-body imaging and a remote medicine network to improve the detection and diagnosis of early-stage melanoma.

Major award for world-leaders in melanoma research
09 Nov 2018

Major award for world-leaders in melanoma research

Professor Georgina Long and Professor Richard Scolyer have been recognised as world leaders in melanoma research for their ground-breaking work that has changed the diagnosis and treatment landscape of melanoma world-wide, and tripled the life-expectancy of advanced melanoma patients.